MICHAEL S. WEISS - 14 Nov 2023 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role
Executive Vice Chairman, Strategic Development, Director
Signature
/s/ Samuel Berry, Attorney-in-Fact
Issuer symbol
FBIO
Transactions as of
14 Nov 2023
Transactions value $
$249,999
Form type
4
Filing time
16 Nov 2023, 17:46:56 UTC
Previous filing
14 Aug 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBIO COMMON STOCK, PAR VALUE $0.001 Purchase $249,999 +147,058 +15% $1.70 1,130,520 14 Nov 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FBIO Warrants to purchase Common Stock Purchase $0 +147,058 $0.000000 147,058 14 Nov 2023 Common Stock 147,058 $1.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
F2 The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70.

Remarks:

Executive Vice Chairman, Strategic Development